A
new draft of the European Union (EU) Guidelines to Good Manufacturing Practice (GMP)
Annex 1, for sterile medicinal products manufacture, has been issued for public
comment. The draft calls on each pharmaceutical manufacturing facility to have
a holistic contamination control strategy in place. The points for inclusion in
such a strategy are alluded to in the draft; this article draws these points
out and provides some examples of what should be included. This may prove to be
a useful framework for GMP facilities to review their practices against.
Tim
Sandle has written an article for GMP Review on one of the main elements of the
new draft guidance for sterile drugs manufacturers, from the European
Commission.
The
reference is:
Sandle,
T. (2018) Annex 1 calls for a contamination control strategy, GMP Review, 16 (3): 4-7
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources